pioglitazone and metformin hydrochloride
pioglitazone and metformin hydrochloride is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Actoplus Met. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- pioglitazone and metformin hydrochloride
- Brand Names
- Actoplus Met
- Application Number
- NDA021842
- Sponsor
- Takeda Pharmaceuticals America, Inc.
- NDC Codes
- 1
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- PIOGLITAZONE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE ACTOPLUS MET is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use ACTOPLUS MET is not recommended to treat type 1 diabetes mellitus or diabetic ketoacidosis. ACTOPLUS MET is a combination of pioglitazone, a thiazolidinedione agonist of peroxisome proliferator receptor gamma, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use : Not recommended for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )